MoneyWorks4Me

Sequent Scientific - Quaterly Results

15 May 2024 Evaluate
The sales for the March 2024 quarter moved down to Rs. 367.71 millions as compared to Rs. 465.95 millions during the year-ago period.The Total Profit for the quarter ended March 2024 of Rs. 37.63 millions grew from Rs.-16.45 millionsOperating Profit saw a handsome growth to 72.34 millions from 19.68 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 367.71 465.95 -21.08 1685.18 2226.85 -24.32 1685.18 2226.85 -24.32
Other Income 129.75 80.13 61.92 459.80 282.42 62.81 459.80 282.42 62.81
PBIDT 72.34 19.68 267.58 193.16 18.82 926.35 193.16 18.82 926.35
Interest 10.25 8.67 18.22 43.61 25.13 73.54 43.61 25.13 73.54
PBDT 62.09 11.01 463.94 87.01 -6.31 -1478.92 87.01 -6.31 -1478.92
Depreciation 21.09 23.31 -9.52 89.40 91.15 -1.92 89.40 91.15 -1.92
PBT 41.00 -12.30 -433.33 -2.39 -97.46 -97.55 -2.39 -97.46 -97.55
TAX 3.37 4.15 -18.80 -8.61 -36.66 -76.51 -8.61 -36.66 -76.51
Deferred Tax 3.37 -3.64 -192.58 -13.20 -30.94 -57.34 -13.20 -30.94 -57.34
PAT 37.63 -16.45 -328.75 6.22 -60.80 -110.23 6.22 -60.80 -110.23
Equity 498.86 498.86 0.00 498.86 498.86 0.00 498.86 498.86 0.00
PBIDTM(%) 19.67 4.22 365.79 11.46 0.85 1256.32 11.46 0.85 1256.32
Peers
Company Name CMP
Sun Pharma. Inds. 1847.00
Dr. Reddys Labs. 1210.45
Cipla 1366.80
Lupin 2119.40
Zydus Lifesciences 1167.20
View more..